The American Journal of Human GeneticsGenetic & Genomic MedicinePeer-reviewed journal article
De novo variants in LDB1 are linked to distinct neurodevelopmental phenotypes determined by variant location and differing pathomechanisms
Rebecca Fluri, Mireia Coll-TanéiD, Theresa BrunetiD, Benjamin CognéiD, Solène ConradiD, Mathilde NizoniD, Francesco NicitaiD, Lorena TravagliniiD, Antonio NovelliiD, Margie Glissmeyer, Amanda Peterson, Jillian G. BuchaniD, Dan Serber, Kolja MeieriD, Jutta GärtneriD, Susann DiegmanniD, Véronique PingaultiD, Tania Attié‐BitachiD, Thomas CourtiniD, Michael C. Schneider, Wing Hung, Inderneel SahaiiD, Lauren O’GradyiD, Katharina SteindliD, Sarju G. MehtaiD, , Anne GregoriD
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 41th percentile
Abstract
LDB1 encodes transcriptional regulator protein LIM-domain-binding protein 1, which plays an important role in neurogenesis. Few C-terminal likely gene disrupting (LGD) variants have been reported in the literature in individuals with congenital ventriculomegaly. Through international collaboration, we now assembled a cohort of 16 individuals with de novo variants affecting various regions of LDB1. Eleven variants affect either the whole gene or the N-terminal dimerization domain (including gene deletions, NMD-sensitive LGD-, and missense variants) and five variants (missense or NMD-escaping LGD variants) affect only the C-terminus of LDB1 containing the LIM interaction domain. All individuals showed variable neurodevelopmental phenotypes, including developmental delay and behavioral anomalies. In line with literature reports, individuals harboring C-terminal variants additionally presented with ventriculomegaly, establishing a genotype-phenotype correlation. In accordance, we found diverging pathomechanisms in vitro: N-terminal missense variants disrupt homodimerization of LDB1, likely leading to a loss of function, while C-terminal variants impair interaction with the essential partner LHX2 in a dominant-negative manner. These findings were confirmed in vivo in Drosophila melanogaster. Toxicity of overexpressed human LDB1 in Drosophila was not observed with N-terminal missense variants but was exacerbated by C-terminal variants. Similarly, phenotypes associated with LDB1/chi loss were rescued by overexpression of wild-type LDB1, but neither by LDB1 harboring N-terminal missense variants nor by C-terminal variants that even worsened phenotypes. In summary, our findings link de novo variants in LDB1 to two overlapping, but distinct neurodevelopmental phenotypes based on variant location, and highlight two separate pathomechanisms underlying LDB1-related neurodevelopmental disorders.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dominant-negative mutations in CBX1 cause a neurodevelopmental disorder
Yukiko Kuroda, Aiko Iwata‐Otsubo, … Kosuke Izumi·bioRxiv·Sep 29, 2020
- Loss of DOT1L disrupts neuronal transcription, behavior, and leads to a neurodevelopmental disorder
Marissa J. Maroni, Melissa Barton, … Erica Korb·medRxiv·Oct 31, 2024
- Expanding the genotype and phenotype spectrum of SYT1-associated neurodevelopmental disorder
Holly Melland, Fabian Bumbak, … Kate Baker·Genetics in MedicinePeer-reviewed·Jan 28, 2022
- De novo missense variants in SLC32A1 cause a neurodevelopmental disorder with epilepsy due to impaired GABAergic neurotransmission
Konrad Platzer, Heinrich Sticht, … Sonja M. Wojcik·Annals of NeurologyPeer-reviewed·Aug 19, 2022
- Expanding clinical and variant spectrum of CBX1-related syndrome: Report of three novel cases
Graciela Carrollo, Shuhei Fujino, … Kosuke Izumi·medRxiv·Sep 28, 2026
- Pathogenic variants in TMEM184B cause a neurodevelopmental syndrome associated with alteration of metabolic signaling
Kimberly A. Chapman, Farid Ullah, … Martha R. C. Bhattacharya·The American Journal of Human GeneticsPeer-reviewed·Aug 29, 2025